Jason Dowd, Ph.D., MBAGlobal Lead Cell Therapy Platform at BayerSpeaker
Profile
Jason Dowd received his PhD from the University of British Columbia from the Michael Smith Biotech Lab and an MBA in Technology Management from the Open University in the UK. He has led the development of several biological products to marketing authorizations in major regulatory jurisdictions through pre-clinical, clinical and commercial stages. Recently at CCRM in Toronto as the Vice-President of Science and Technology, he led several research, development and GMP initiatives. Jason has returned to therapeutic product development with Bayer with a global role in allogeneic cell therapy platform development. Jason also has an adjunct professor role in the School of Engineering at McMaster University.
Agenda Sessions
Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms
, 10:00amView Session